SCN3B

SCN3B encodes the voltage-gated sodium channel β3 auxiliary subunit (Navβ3), which physically associates with the pore-forming α-subunit Nav1.5 (SCN5A) to promote its trafficking to the plasma membrane and modulate channel gating — increasing functional sodium channel expression, shifting steady-state inactivation, and accelerating recovery from inactivation (PMID:11744748, PMID:20042427). Scn3b-knockout mice exhibit reduced ventricular sodium current density, sinus node dysfunction, conduction slowing, and inducible ventricular tachycardia and atrial fibrillation, establishing Navβ3 as essential for normal cardiac electrical function (PMID:19351516, PMID:19796257). Loss-of-function SCN3B mutations cause Brugada syndrome, idiopathic ventricular fibrillation, and atrial fibrillation through reduced Nav1.5 current arising from impaired trafficking, altered gating, or dominant-negative suppression of channel conductance (PMID:20042427, PMID:20558140, PMID:23257389, PMID:21051419). SCN3B transcription is directly activated by p53 via intronic and upstream response elements and by GATA4 at the 5′UTR, and SCN3B overexpression induces apoptosis, linking the gene to a p53-dependent cell-death pathway at the endoplasmic reticulum (PMID:15334053, PMID:36362949).

1. 2001 High

   The fundamental question of whether the β3 subunit modulates the cardiac sodium channel was answered: co-expression with Nav1.5 increased functional channel expression ~3-fold, shifted inactivation, and accelerated recovery, establishing SCN3B as a kinetic and trafficking modulator of Nav1.5.

   Evidence Xenopus oocyte co-expression with macropatch electrophysiology

   PMID:11744748

   Open questions at the time

   • Physical interaction between β3 and Nav1.5 was not directly demonstrated
   • In vivo cardiac relevance not yet tested
   • Mechanism of increased functional expression (trafficking vs. gating) unresolved
2. 2004 High

   The unexpected finding that p53 directly transactivates SCN3B and that SCN3B overexpression induces apoptosis placed the sodium channel subunit in a p53-dependent cell-death pathway at the endoplasmic reticulum, broadening its biology beyond ion conduction.

   Evidence ChIP for p53 binding, luciferase reporter assays, adenoviral overexpression with colony formation and apoptosis assays, immunofluorescence localization

   PMID:15334053

   Open questions at the time

   • Downstream apoptotic mechanism (how ER-localized β3 triggers cell death) undefined
   • Relevance of the p53–SCN3B axis in cardiac tissue not explored
   • No confirmation that endogenous sodium currents mediate the apoptotic effect
3. 2009 High

   Loss of Scn3b in knockout mice demonstrated in vivo cardiac necessity: reduced sodium current, ventricular tachycardia susceptibility, sinus node dysfunction, and atrial fibrillation established Navβ3 as required for normal cardiac conduction and rhythm.

   Evidence Scn3b−/− knockout mice with whole-cell patch clamp of isolated myocytes, in vivo ECG, Langendorff perfusion with programmed electrical stimulation

   PMID:19351516 PMID:19796257

   Open questions at the time

   • Whether β3 loss alters expression/localization of other β subunits or compensatory channels not addressed
   • Mechanism linking reduced current to arrhythmia substrate (fibrosis, gap junctions) not defined
4. 2009 High

   The first human disease-causing mutation (V54G) was shown to reduce Nav1.5 trafficking to the plasma membrane and decrease sodium current, establishing a direct physical association by co-immunoprecipitation and linking SCN3B loss-of-function to Brugada syndrome.

   Evidence Whole-cell patch clamp in HEK-293 and COS cells, co-immunoprecipitation, immunocytochemistry

   PMID:20042427

   Open questions at the time

   • Structural basis for how V54G disrupts trafficking unknown
   • Whether V54G also affects interaction with other Nav α subunits not tested
5. 2010 High

   Multiple SCN3B mutations in atrial fibrillation patients revealed that β3 dysfunction can operate through at least two distinct mechanisms — impaired trafficking (most mutations) versus dominant-negative suppression of ion conduction without trafficking defect (A130V) — diversifying the pathophysiological repertoire.

   Evidence Whole-cell patch clamp, co-expression dominant-negative assay, surface biotinylation in HEK293 cells

   PMID:20558140 PMID:21051419

   Open questions at the time

   • Structural basis for dominant-negative mechanism of A130V unknown
   • Whether dominant-negative mutations affect other sodium channel isoforms untested
6. 2016 High

   High SCN3B expression in embryonic/iPSC-derived cardiomyocytes was shown to mask the Brugada syndrome phenotype of SCN5A mutations, explaining why BrS manifests in adulthood when SCN3B expression declines, and an IL-2/p53 axis was identified that upregulates SCN3B transcription.

   Evidence iPSC-derived cardiomyocytes with siRNA knockdown and heterologous expression electrophysiology; qRT-PCR, Western blot, and patch clamp for IL-2 studies

   PMID:26728597 PMID:27677334

   Open questions at the time

   • Developmental regulation of SCN3B expression in human heart not mapped in vivo
   • IL-2 effect on sodium current was partly independent of SCN3B, suggesting additional mediators
7. 2022 Medium

   Identification of GATA4 as a transcriptional regulator of SCN3B via the 5′UTR and a miR-190a-5p/IL-2/SCN3B regulatory axis extended the upstream control network governing SCN3B expression in the heart.

   Evidence Luciferase reporter assays, transcription factor binding analysis, qRT-PCR, whole-cell patch clamp

   PMID:35083300 PMID:36362949

   Open questions at the time

   • GATA4 regulation not confirmed by ChIP in cardiac cells
   • Physiological relevance of miR-190a-5p axis in cardiac tissue in vivo not demonstrated
   • Interplay between GATA4 and p53 regulatory inputs uncharacterized
8. 2025 High

   Structural-functional dissection of the ΔT138 in-frame deletion showed that β3 mutations can alter Nav1.5 gating (reducing current and accelerating inactivation) without disrupting β3 structure, surface expression, or physical interaction with Nav1.5, defining a third loss-of-function mechanism — pure gating modulation.

   Evidence Site-directed mutagenesis, circular dichroism spectroscopy, whole-cell patch clamp, surface biotinylation, co-immunoprecipitation

   PMID:39761910

   Open questions at the time

   • Atomic-resolution structure of β3–Nav1.5 complex not available
   • Whether ΔT138 mechanism applies in cardiomyocytes not tested

• Key unresolved questions include the atomic structure of the β3–Nav1.5 interface, the mechanism by which ER-localized β3 induces p53-dependent apoptosis, and whether β3 modulates neuronal or other non-cardiac sodium channel isoforms in vivo.
• No high-resolution structure of β3 alone or in complex with Nav1.5
• Apoptotic mechanism downstream of β3 at the ER undefined
• Role of β3 with non-cardiac Nav α-subunits not functionally characterized in native tissues